US90184D1000 - Common Stock
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today.
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued growth momentum. Analysts reaffirm Outperform ratings.
Which stocks are experiencing notable movement on Friday?
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
TWST stock results show that Twist Bioscience beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Twist Bioscience (NASDAQ:TWST) just reported results for the second quarter of ...
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.
These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips While 2023 was the year of the Magnificent Seven, the seven outperforming stock...